Clearmind files U.S. patent for MDMA-PEA combination to treat PTSD
Go back to Clearmind files U.S. patent for MDMA-PEA combination to treat PTSD| (NASDAQ: CMND) | Delayed: 1.03 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.03 | 52 Week High | $ | |||
| Open | $1.03 | 52 Week Low | $ | |||
| Day High | $1.03 | P/E | N/A | |||
| Day Low | $1.03 | EPS | $ | |||
| Volume | 40,685 | |||||
